Алямкина Екатерина Анатольевна (RU),Долгова Евгения Владимировна (RU),Проскурина Анастасия Сергеевна (RU),Николин Валерий Петрович (RU),Попова Нелли Александровна (RU),Орищенко Константин Евгеньевич (
申请号：
RU2010141597/15
公开号：
RU2010141597A
申请日:
2010.10.12
申请国别(地区):
RU
年份:
2012
代理人:
摘要：
1. A method for the treatment of cancer based on the introduction into the patient groups cytostatic drugs doxorubicin and cyclophosphamide destroying tumor cells and forming debris immunogenic cancer cells, characterized in that it further with cytostatic drugs administered group administered drug into the body of fragmented double stranded human DNA fragments with having a biologically active size and constituting the complete genome of physiologically and genetically healthy donor. ! 2. A method according to claim 1, characterized in that the preparation of fragmented double stranded human DNA with fragments having biologically active components of resolution and the complete genome of physiologically and genetically healthy donor is introduced in the form of tablets containing 5 mg of active ingredient, according to the scheme after 30 min and 2, 3 and 5 days after administration of cyclophosphamide in an amount of one tablet during the first 30 min after administration of Cy, and more in these days, one tablet every 2-3 hours during the day (the waking time) but not more than the maximum number of Equal to 30 mg of active ingredient per day. ! 3. A method according to claim 1, characterized in that the preparation of fragmented double stranded human DNA with fragments having biologically active components of resolution and the complete genome of physiologically and genetically healthy donor is used as a substrate for the activation of maturation, induction of antigen-specific and allostimulatory activity towards Th1 path dendritic antigen-presenting cells.1. Способ лечения онкологических заболеваний, основанный на введении в организм пациента препаратов цитостатической группы доксорубицина и циклофосфана, разрушающих опухолевые клетки и формирующих иммуногенный дебрис раковых клеток, отличающийся тем, что дополнительно с вводимыми препаратами цитостатической группы в организм вводят препарат фрагментированной двуцепочечной ДНК человека с фрагментами, имеющими б
